Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma.
BACKGROUND: Although the association between mitral stenosis (MS) and increased coagulation activity is well recognized, it is unclear whether enhanced coagulation remains localized in the left atrium or whether this represents a systemic problem. To assess systemic coagulation parameters and changes in platelet aggregation, we measured fibrinogen levels and performed in vitro platelet function tests in plasma obtained from mitral stenotic patients' and from healthy control subjects' peripheral venous blood. METHODS: Sixteen newly diagnosed patients with rheumatic MS (Group P) and 16 healthy subjects (Group N) were enrolled in the study. Platelet-equalized plasma samples were evaluated to determine in vitro platelet function, using adenosine diphosphate (ADP), collagen and epinephrine in an automated aggregometer. In vitro platelet function tests in group N were performed twice, with and without plasma obtained from group P. RESULTS: There were no significant differences between the groups with respect to demographic variables. Peripheral venous fibrinogen levels in Group P were not significantly different from those in Group N. Adenosine diphosphate, epinephrine and collagen-induced platelet aggregation ratios were significantly higher in Group P than in Group N. When plasma obtained from Group P was added to Group N subjects' platelets, ADP and collagen-induced, but not epinephrine-induced, aggregation ratios were significantly increased compared to baseline levels in Group N. CONCLUSION: Platelet aggregation is increased in patients with MS, while fibrinogen levels remain similar to controls. We conclude that mitral stenotic patients exhibit increased systemic coagulation activity and that plasma extracted from these patients may contain some transferable factors that activate platelet aggregation.
Tengiz
Istemihan
I
Department of Cardiology, Central Hospital, 1644 sk, No:2/2, 35010 Bayrakli, Izmir, Turkey. dritengiz@yahoo.com.
Ercan
Ertugrul
E
Sahin
Fahri
F
Alioglu
Emin
E
Duman
Can
C
Saydam
Guray
G
Buyukkececi
Filiz
F
J Am Coll Cardiol. 1995 Jan;25(1):107-12
7646626
Eur Heart J. 2001 Sep;22(17):1561-71
11492985
Blood. 1987 Aug;70(2):343-50
3607275
Br Heart J. 1991 Jul;66(1):22-5
1854571
Blood Rev. 1990 Mar;4(1):25-40
2182146
Chest. 1994 Aug;106(2):396-9
7774309
Circulation. 1978 Dec;58(6):1072-83
709763
Postgrad Med J. 1971 Sep;47(551):599-604
5098918
Fukuoka Igaku Zasshi. 1991 Nov;82(11):550-61
1774012
Chest. 1997 Apr;111(4):929-33
9106571
Semin Thromb Hemost. 1991 Oct;17(4):433-8
1803514
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1990;33(3):325-33
2087628
Am J Cardiol. 1998 Mar 15;81(6):795-7
9527099
Angiology. 2003 Sep-Oct;54(5):593-7
14565635
Am J Cardiol. 1999 Apr 15;83(8):1206-9
10215285
Circulation. 1979 Nov;60(5):1096-104
487543
Int J Card Imaging. 1992;8(3):197-207
1527442
Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1042-8
2960241
Circulation. 1996 Aug 1;94(3):331-9
8759073
Cardiology. 1994;85(2):69-75
7954565